427 related articles for article (PubMed ID: 10688973)
21. Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites.
Nicholson JR; Paterson SJ; Menzies JR; Corbett AD; McKnight AT
Can J Physiol Pharmacol; 1998 Mar; 76(3):304-13. PubMed ID: 9673794
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
[TBL] [Abstract][Full Text] [Related]
23. Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ.
Berger H; Albrecht E; Wallukat G; Bienert M
Br J Pharmacol; 1999 Feb; 126(3):555-8. PubMed ID: 10188961
[TBL] [Abstract][Full Text] [Related]
24. Nociceptin/orphanin FQ: role in nociceptive information processing.
Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
[TBL] [Abstract][Full Text] [Related]
25. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
27. Nociceptin binding sites in frog (Rana esculenta) brain membranes.
Benyhe S; Monory K; Farkas J; Tóth G; Guerrini R; Salvadori S; Orosz G; Wollemann M; Borsodi A
Biochem Biophys Res Commun; 1999 Jul; 260(3):592-6. PubMed ID: 10403810
[TBL] [Abstract][Full Text] [Related]
28. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats.
Pomonis JD; Billington CJ; Levine AS
Neuroreport; 1996 Dec; 8(1):369-71. PubMed ID: 9051812
[TBL] [Abstract][Full Text] [Related]
29. Dual coupling of opioid receptor-like (ORL1) receptors to adenylyl cyclase in the different layers of the rat main olfactory bulb.
Onali P; Ingianni A; Olianas MC
J Neurochem; 2001 Jun; 77(6):1520-30. PubMed ID: 11413235
[TBL] [Abstract][Full Text] [Related]
30. Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung.
Corboz MR; Rivelli MA; Egan RW; Tulshian D; Matasi J; Fawzi AB; Benbow L; Smith-Torhan A; Zhang H; Hey JA
Eur J Pharmacol; 2000 Aug; 402(1-2):171-9. PubMed ID: 10940371
[TBL] [Abstract][Full Text] [Related]
31. N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.
Judd AK; Kaushanskaya A; Tuttle DJ; Sanchez A; Khroyan T; Polgar W; Toll L
J Pept Res; 2003 Nov; 62(5):191-8. PubMed ID: 14531842
[TBL] [Abstract][Full Text] [Related]
32. Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors.
Zaveri N; Polgar WE; Olsen CM; Kelson AB; Grundt P; Lewis JW; Toll L
Eur J Pharmacol; 2001 Sep; 428(1):29-36. PubMed ID: 11779034
[TBL] [Abstract][Full Text] [Related]
33. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
Olianas MC; Concas D; Onali P
Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
[TBL] [Abstract][Full Text] [Related]
35. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
Meunier JC
Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
[TBL] [Abstract][Full Text] [Related]
36. Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.
Sbrenna S; Marti M; Morari M; Calo' G; Guerrini R; Beani L; Bianchi C
Br J Pharmacol; 2000 May; 130(2):425-33. PubMed ID: 10807682
[TBL] [Abstract][Full Text] [Related]
37. (8-Naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4. 5]dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist.
Thomsen C; Hohlweg R
Br J Pharmacol; 2000 Nov; 131(5):903-8. PubMed ID: 11053209
[TBL] [Abstract][Full Text] [Related]
38. Modulation of enkephalin release by nociceptin (orphanin FQ).
Gintzler AR; Adapa ID; Toll L; Medina VM; Wang L
Eur J Pharmacol; 1997 Apr; 325(1):29-34. PubMed ID: 9151935
[TBL] [Abstract][Full Text] [Related]
39. Characterization of specific [3H]nociceptin binding in rat brain and spinal cord.
Kusaka T; Yamada S; Kimura R
Biol Pharm Bull; 2001 Aug; 24(8):902-5. PubMed ID: 11510482
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray.
Chiou LC
J Biomed Sci; 2000; 7(3):232-40. PubMed ID: 10810242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
